Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on May 26, 2016. The report details a material definitive agreement entered into on the same date regarding the company's credit facilities.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. However, it discloses specific debt metrics related to the Tranche B-1 Term Loan:
- Outstanding Principal: $493.8 million (as of March 31, 2016).
- Applicable Rate Reduction (Eurodollar Rate Loans): Reduced from 3.50% to 3.00%.
- Applicable Rate Reduction (Base Rate Loans): Reduced from 2.50% to 2.00%.
Material Changes
The primary material change is the execution of the Tranche B-1 Repricing Amendment to the Amended and Restated Credit Agreement (originally dated December 31, 2012). This amendment lowers the interest rates applicable to the outstanding Tranche B-1 Term Loan, resulting in reduced interest expense for the company.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard incorporation of the amendment terms. The document notes that the summary of terms is qualified in its entirety by reference to the full Amendment attached as Exhibit 10.
Key Facts for Investor Verification
- Verify the exact effective date of the interest rate reduction in the full Tranche B-1 Repricing Amendment (Exhibit 10).
- Confirm the total outstanding balance of the Tranche B-1 Term Loan as of the most recent quarter to calculate the precise annual interest savings.
- Review the full Credit Agreement to understand any covenants or conditions attached to the repricing.
- Check subsequent filings for any further amendments to the credit facility or changes in the outstanding debt balance.